What is the recommended trigger‑free anesthetic plan for a patient with a known history of malignant hyperthermia and an anesthetic allergy?

Malignant Hyperthermia and Anesthetic Allergy: Trigger-Free Anesthetic Management

For patients with known malignant hyperthermia susceptibility, use total intravenous anesthesia (TIVA) with propofol as the primary anesthetic technique, completely avoiding all volatile inhalational agents and succinylcholine. 1, 2

Absolute Contraindications (Triggering Agents)

The following agents must never be used in MH-susceptible patients:

• All volatile inhalational anesthetics (sevoflurane, desflurane, isoflurane, halothane, methoxyflurane) 1, 2
• Succinylcholine (depolarizing muscle relaxant) 1, 2, 3

These are the only agents that trigger MH; all other anesthetic drugs are safe. 2

Safe Anesthetic Agents (Non-Triggering)

The following agents are confirmed safe for MH-susceptible patients:

• Propofol (first-line agent for TIVA) 2
• Nitrous oxide 2, 4
• All intravenous induction agents (except succinylcholine) 2
• Benzodiazepines (including remimazolam) 2
• All opioids 2
• Non-depolarizing muscle relaxants (rocuronium, vecuronium, atracurium) 2, 4
• Local anesthetics 4
• Xenon 4

Anesthetic Machine Preparation

Critical preparation steps before anesthesia:

• Purge the anesthesia machine with 100% oxygen at high flow until residual volatile agent concentration is < 5 ppm 2
• Modern anesthesia workstations require longer purging times than older machines due to increased gas-absorbing materials 5
• Install activated charcoal filters in the breathing circuit to adsorb trace volatile agents 6, 2
• Disconnect or remove vaporizers (do not waste time changing the entire circuit during a crisis) 1

Important caveat: Current purging guidelines were developed for older machines and may be inadequate for newer generation workstations, which contain more gas-absorbing materials and require extended preparation time. 5

Preferred Anesthetic Technique Algorithm

Step 1: Consider Regional Anesthesia First

• Regional anesthesia is the preferred technique when feasible 2
• Options include spinal, epidural, or peripheral nerve blocks 7
• Note: Peripheral nerve blocks have a 39.4% failure rate in this population, particularly in patients > 23.5 years old or > 59.5 kg 7
• Subarachnoid anesthesia has an 11.8% failure rate 7

Step 2: If General Anesthesia Required

• Use TIVA with propofol as the primary maintenance agent 1, 2
• Combine with non-depolarizing muscle relaxants if paralysis needed 2
• Add opioids for analgesia 2
• Nitrous oxide may be used as adjunct 2, 4

Prophylactic Dantrolene: NOT Recommended

Do not administer prophylactic dantrolene before anesthesia in MH-susceptible patients. 8, 2, 9 This recommendation is based on consensus that complete avoidance of triggering agents eliminates the need for prophylaxis.

Intraoperative Monitoring

Standard anesthetic monitoring plus:

• End-tidal CO₂ (early sign: unexplained hypercarbia > 55 mmHg) 6, 3
• Core temperature (rapid rise > 0.5°C/15 min is typical) 3
• Continuous ECG (watch for tachycardia, arrhythmias) 1
• Arterial blood gases if crisis suspected 1
• Serum potassium and creatine kinase 1, 3

Postoperative Care

• Minimum 24-hour observation period in recovery, HDU, or ICU 1, 2
• MH crises can occur during or shortly after anesthesia, even in patients with previous uneventful anesthesia 1, 2
• Recurrence can occur up to 24 hours after initial event 2
• For ambulatory surgery: patients may be discharged when usual discharge criteria are met (no extended stay required if no trigger exposure occurred) 9

Emergency Preparedness

Dantrolene must be immediately available:

• Initial dose: 2-3 mg/kg IV 6
• Repeat 1 mg/kg every 5 minutes until crisis resolves 6
• Continue until ETCO₂ < 6 kPa with normal ventilation and core temperature < 38.5°C 6
• Stock at least 36-50 ampoules for adult patients 1
• Maximum dose may need to exceed 10 mg/kg 1

Addressing Anesthetic Allergy Concerns

When a patient reports "anesthetic allergy" in addition to MH susceptibility:

• Obtain detailed history of the specific reaction (timing, symptoms, agents involved) 6
• True IgE-mediated anesthetic allergies are rare; most reactions are non-allergic 6
• Propofol is contraindicated only in patients with documented egg, soy, or propofol allergy
• Alternative TIVA agents include benzodiazepines (midazolam) with ketamine if propofol cannot be used
• Local anesthetics are safe in MH and can be used for regional techniques 4
• Consider allergy testing preoperatively if true drug allergy suspected

Common Pitfalls to Avoid

• Do not assume older machine preparation protocols work for modern workstations 5
• Do not delay treatment while waiting for temperature elevation—hypercarbia and tachycardia appear first 6, 3
• Do not confuse MH susceptibility with other myopathies—association remains debated 4
• Do not discharge patients before 24-hour observation period if any trigger exposure occurred 1, 2
• Do not forget to refer suspected MH cases to specialized testing centers for family counseling 6